ES2008956A6 - Monoclonal antibody specific to human neutrophil(s) - produced by new hybridoma cell line ATCC-HB-9445 derived from mouse spleen cells immunised with purified human granulocytes
- Google Patents
Monoclonal antibody specific to human neutrophil(s) - produced by new hybridoma cell line ATCC-HB-9445 derived from mouse spleen cells immunised with purified human granulocytes
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Corp
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/070,202external-prioritypatent/US4931395A/en
Application filed by Coulter CorpfiledCriticalCoulter Corp
Publication of ES2008956A6publicationCriticalpatent/ES2008956A6/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
A cell line is claimed, produced by a hybridoma technique, which produces a monoclonal antibody which binds specifically to the ID3 antigen of neutrophils. Monoclonal antibody is also claimed, which binds specifically to the ID3 antigen and is further characterised as not binding to human acute leukemia cells and other human peripheral blood cells and not binding significantly to granulocyte precursors in bone marrow.
ES8800066A1987-07-061988-01-12Monoclonal antibody specific to human neutrophil(s) - produced by new hybridoma cell line ATCC-HB-9445 derived from mouse spleen cells immunised with purified human granulocytes
ExpiredES2008956A6
(en)
Monoclonal antibody specific to human neutrophil(s) - produced by new hybridoma cell line ATCC-HB-9445 derived from mouse spleen cells immunised with purified human granulocytes
Monoclonal antibody specific to a human carcinoma tumor-associated antigen kc-4,hybrid cell lines producing the same,pharmaceutical compositions containing them and methods for the use thereof
Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
Monoclonal antibody specific to human neutrophil(s) - produced by new hybridoma cell line ATCC-HB-9445 derived from mouse spleen cells immunised with purified human granulocytes
Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor
Prognostic Relevance of Surface Markers in Adult de novo Acute Myeloblasts Leukemias: A Prospective Study of the Groupe d'Etude Immunologique des Leucemies (GEIL)
Purified antigen isolated from sera of leukemia and lymphoma patients,novel antibodies to said antigen,methods of preparing same and diagnostic and therapeutic methods employing said antibody